Expression of PDGF and its receptor as well as their relationship to proliferating activity and apoptosis of meningiomas in human meningiomas.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Journal of clinical neuroscience

• Publication date

  2001-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1054/JOCN.2001.0877PMID 11386826
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recurrence of meningiomas

  2000cited by this paper
• Proliferation and Dna fragmentation in meningioma subtypes

  1997cited by this paper
• Detection of activated platelet-derived growth factor receptors in human meningioma.

  1997cited by this paper
• Prognostic factors for survival in cervical cancer--warts and all.

  1996cited by this paper
• Significance of proliferating cell nuclear antigen in predicting recurrence of intracranial meningioma.

  1996cited by this paper
• Tumor type is a determinant of susceptibility to apoptosis.

  1995cited by this paper
• Control of meningioma cell growth by platelet-derived growth factor (PDGF).

  1995cited by this paper
• Transformation of follicular lymphoma. Expression of p53 and bcl-2 oncoprotein, apoptosis and cell proliferation.

  1995cited by this paper
• Expression of PDGF, PDGF-Receptor, EGF-Receptor and sex hormone receptors on meningioma

  1994cited by this paper
• Apoptosis in disease

  1994cited by this paper
• Platelet–derived growth factor (PDGF) and receptor (PDGFR) expression in human meningiomas: correlations with clinicopathological features and cytogenetic analysis

  1994cited by this paper
• Expression of PDGF beta-receptors in human meningioma cells.

  1990cited by this paper
• Human meningiomas co‐express platelet‐derived growth factor (pdgf) and pdgf‐receptor genes and their protein products

  1990cited by this paper
• Expression of PDGF β‐receptors in human meningioma cells

  1990cited by this paper
• Incidence and clinicopathological features of meningioma.

  1989cited by this paper
• Immunohistochemical detection of proliferating cell nuclear antigen in solid human malignancies.

  1987cited by this paper
• The biology of platelet-derived growth factor

  1986cited by this paper
• Chromosome translocation t(14;22) and oncogene (c-sis) variant in a pedigree with familial meningioma.

  1985cited by this paper
• Meningioma: analysis of recurrence and progression following neurosurgical resection.

  1985cited by this paper
• Meningiomas : their classification, regional behaviour, life history, and surgical end results

  1938cited by this paper
• THE RECURRENCE OF INTRACRANLAL MENINGIOMAS AFTER SURGICAL TREATMENT

  year unknowncited by this paper

• Advances in the systemic therapy for recurrent meningiomas and the challenges ahead

  2023cites this paper
• Drug target therapy and emerging clinical relevance of exosomes in meningeal tumors

  2023cites this paper
• The expression of platelet-derived growth factor and its receptor in canine and feline meningiomas

  2023cites this paper
• 36 Meningiomas Meningiomas

  2021cites this paper
• Recent Advances in Meningioma Immunogenetics

  2020cites this paper
• Convexity meningioma resection in the modern neurosurgical era.

  2020cites this paper
• Medical management of meningiomas.

  2020cites this paper
• An expanded analysis framework for multivariate GWAS connects inflammatory biomarkers to functional variants and disease

  2019cites this paper
• Adipose-derived stem cell-conditioned medium protects fibroblasts at different senescent degrees from UVB irradiation damages

  2019cites this paper
• Emerging Medical Treatments for Meningioma in the Molecular Era

  2018cites this paper
• Collision Tumor of Glioblastoma and Meningioma: Case Report and Literature Review.

  2018cites this paper
• Letter: Role of Tyrosine Kinase Inhibitors in Recurrent Meningiomas: Controversies and Promises.

  2018cites this paper
• Medical management of meningioma in the era of precision medicine.

  2018cites this paper
• Atypical and Malignant Meningiomas

  2017cites this paper
• Receptor tyrosine kinase inhibition by regorafenib/sorafenib inhibits growth and invasion of meningioma cells.

  2017cites this paper
• Dramatic radiographic response resulting in cerebrospinal fluid rhinorrhea associated with sunitinib therapy in recurrent atypical meningioma: case report.

  2017cites this paper
• Glioblastoma Simultaneously Present with Adjacent Meningioma: Case report

  2016cites this paper
• Identifying Common Therapeutic Targets in Merlin-deficient Brain Tumours

  2016cites this paper
• Systemic therapy for recurrent meningioma

  2016cites this paper
• Astrocytoma simultaneously present with Meningioma-a report of two cases and review of the literature

  2016cites this paper
• Patterns of protein expression and cytogenetic alterations in meningiomas: relationship with the clinical and biological features of the disease

  2015influential citation
• The protein expression profile of meningioma cells is associated with distinct cytogenetic tumour subgroups

  2015cites this paper
• Analysis of genomic mutation and immunohistochemistry of platelet-derived growth factor receptors in canine vascular tumours.

  2015cites this paper
• Phase II trial of sunitinib for recurrent and progressive atypical and anaplastic meningioma.

  2015cites this paper
• Innovative Therapeutic Strategies in the Treatment of Meningioma.

  2015cites this paper
• Systemic Treatment of Recurrent Meningioma

  2013cites this paper
• Recent developments in chemotherapy for meningiomas: a review.

  2013cites this paper
• Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.

  2013cites this paper
• Medical management of meningiomas.

  2013cites this paper
• Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.

  2013cites this paper
• Recurrent anaplastic meningioma treated by sunitinib based on results from quantitative proteomics

  2012cites this paper
• Management of Malignant Meningiomas

  2012cites this paper
• Sunitinib targets PDGF-receptor and Flt3 and reduces survival and migration of human meningioma cells.

  2012cites this paper
• Clinicopathological evaluation of cyclooxygenase-2 expression in meningioma: immunohistochemical analysis of 76 cases of low and high-grade meningioma

  2012cites this paper
• Badania kliniczno-molekularne w oponiakach

  2012cites this paper
• Chemotherapy: what is its role in meningioma?

  2012cites this paper
• Vascular endothelial growth factor signals through platelet-derived growth factor receptor β in meningiomas in vitro

  2012cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments.

  2011cites this paper
• Emerging therapeutic targets in schwannomas and other merlin-deficient tumors

  2011cites this paper
• Phase II study of Gleevec® plus hydroxyurea (HU) in adults with progressive or recurrent meningioma

  2011cites this paper
• The molecular genetics and tumor pathogenesis of meningiomas and the future directions of meningioma treatments

  2011cites this paper
• CHAPTER 7 – Biology of Meningiomas

  2010cites this paper
• Risk profile associated with convexity meningioma resection in the modern neurosurgical era.

  2010cites this paper
• CHAPTER 56 – Chemotherapy and Experimental Medical Therapies for Meningiomas

  2010cites this paper
• Glioblastoma simultaneously present with adjacent meningioma: case report and review of the literature

  2010cites this paper
• Medical therapies for meningiomas

  2010cites this paper
• Molecular biological determinants of meningioma progression and aggressive behavior.

  2009cites this paper
• Molecular Basis of Meningioma Tumorigenesis and Progression

  2009cites this paper
• Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

  2009cites this paper
• [Immunohistochemical expression of progesterone receptor in relationship with histological grade and risk of relapses in intracranial meningiomas].

  2009cites this paper
• Titanium alloy cage implantation for the treatment of ischemic necrosis of femoral head in dogs

  2008cites this paper
• Estudio clínico-patológico comparativo de los meningiomas con referencia a su grado histológico y riesgo de recidivas

  2008cites this paper
• Expresión inmunohistoquímica de la proteína p53 en relación con el grado histológico y riesgo de recidivas en meningiomas intracraneanos

  2008cites this paper
• Characterization of the AP-1 and NF-kappa B transcription factors in the U-87 astrocytoma cell line

  2008cites this paper
• Platelet-Derived Growth Factor Pathway Inhibitors in Ovarian Cancer

  2008cites this paper
• Molecular pathogenesis of adult brain tumors and the role of stem cells.

  2007cites this paper
• Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.

  2007cites this paper
• Myofibroblastic Sarcoma in Meningioma: A New Variant of “Metaplastic” Meningioma

  2007cites this paper
• Association between absence of epidermal growth factor receptor immunoreactivity and poor prognosis in patients with atypical meningioma.

  2007cites this paper
• Targeted drug therapy for meningiomas.

  2007cites this paper
• Diagnostic and molecular pathology of meningiomas

  2006cites this paper
• Chemotherapy of Meningiomas

  2006cites this paper
• Novel therapies for meningiomas

  2006cites this paper
• High throughput screening of meningioma biomarkers using a tissue microarray

  2005cites this paper
• Molecular Pathology of Nervous System Tumors

  2005cites this paper
• Meningothelial Hyperplasia: A Detailed Clinicopathologic, Immunohistochemical and Genetic Study of 11 Cases

  2005cites this paper
• Diagnosis and Treatment of Atypical and Anaplastic Meningiomas: A Review

  2005cites this paper
• Sex Steroid and Growth Factor Profile of a Meningioma Associated with Pregnancy

  2005cites this paper
• Molecular pathogenesis of meningiomas

  2004cites this paper
• Book Review

  2003cites this paper
• The role of growth factors in central nervous system tumours.

  2003cites this paper
• Overview of Meningioma Biology and Science

  2003cites this paper
• Growth Factor Expression in Central Nervous System Tumours

  2003cites this paper
• Paracrine and autocrine functions of PDGF in malignant disease.

  2002cites this paper